What Makes PhotoMed Technologies Unique?

By Allan Gardiner, Founder

Most people do not experience chronic pain. Innate self-healing repairs acute damage and life goes on. Their acute pain experience concludes to become a memory in the past.

For others, the pain experience feels fresh after healing has otherwise completed.


Chronic pain is an experience that defies objective communication, like the color red of a ladybug.

Perhaps you, as I, have never experienced significant or chronic pain. How can we conjure our "worst imaginable pain" as most chronic pain patients are asked to do? I do not know.

Here's an experiment that you can do in thought or for real:

  1. Plunge your hand into ice water. Feel the shock, then the cold, then the tingling. Bad, but probably not worst...
  2. Pay attention to the changing sensations from coldness to burning (like holding ice or a blow torch). Bad and perhaps the worst?
  3. Pay close attention to the weird little sensations, then the stiffness. Perhaps the worst has passed.
  4. Pay attention to the numbness and loss of sensation. Ah, not so bad...
  5. Remove your hand and pay attention as sensations come and go. I call this phase "the return-toward-normal function" that occurs when PhotoMed's therapy "works."

Now imagine combinations of different sensations, pain, and impairments "stuck" for the rest of your life!


Here are a few combinations to consider:


PhotoMed's team prefers to record objective measures of functional improvement that can be re-examined to help answer new questions.


The problem we solve

For 100 million Americans, chronic pain feels fresh for a lifetime. Modern medicines reduce the pain for millions. But 40 million endure chronic pain unmanaged by existing technologies.

"Chronic" tells everyone to expect the pain will not leave any time soon.

PhotoMed Technologies introduces the first exit strategy for this epidemic.


The people we serve

Graphic illustrating PhotoMed Technologies return-toward-normal function.PhotoMed's team invented methods and tools to solve one of the world’s most challenging problems – how to end unresponsive chronic pain.

Our patient-centered study methods welcome and serve people excluded from traditional studies for lack of expected improvement. They are the people who most urgently need a solution.

Now, pioneers can efficiently prompt the return of innate functions, called normal, that remove the need for pain or for it to resume. Curiously, only previously unresponsive chronic pain appears to fully complete the switch to normal.

Cases from my personal files offer but a glimpse of the possible. Each case reveals an outcome not predicted by current textbooks or national-level discussions about pain and impairment. Each case invites a new area of study using PhotoMed's tools.

My family and I founded and funded PhotoMed and patient-centered to help people with no path forward. Growing up, we shared our lives with friends and neighbors with chronic pain, polio, MS, and other disorders. They taught us important lessons about hope and perseverance that drives us to continue our quest.

Our efforts have helped many people through studies. Now you can help your neighbors by spreading word that chronic pain and impairments can end.


Our tools launch a new era

PhotoMed's team invented methods and tools that enable pioneers to open new areas of study and care, just as did the microscope, X-ray, and MRI…


PhotoMed's study methods consider and examine chronic pain as an interruption rather than a life sentence. PhotoMed's tools prompt and document the beginning of a return-toward-normal function.


The concept of an interruption includes the possibility that pain and associated impairments, usually symptoms, can vanish. The transition, small or astoundingly large, reflects the degree of impairment rather than the method for arriving at the intersection between "chronic" and normal. The response, such as warming, marks the body's resumption of innate functions.

For most people, the return-toward-normal function occurs at the proper time such that a "chronic" state doesn't begin.

Traditional studies that aim to find a dose-response relationship over more than one visit miss the opportunity to watch chronic pain vanish.


Perhaps PhotoMed's therapy provides a signal, or a distraction, needed for normal to get going again.

It is easier to observe an abrupt return-toward-normal function than to measure subtle changes in ongoing pain.


PhotoMed’s Rapid Discovery System manages and records the steps taken to achieve the end of a pain experience.


Re-examination of recorded data invites and helps answer new questions.


The questions you can now ask

PhotoMed’s pioneering quest began with only a single clue; light can prompt the body to heal. That was in 2000.  Curiosity compelled our team to invent tools that capture data before the questions could be known.


PhotoMed’s tools let pioneers explore the body’s self-repair systems in action. The focus shifts from ongoing pain relief to the restoration of innate functions; sensory, motor, thermoregulation, and coordination.

Discoveries yield more questions than answers. What questions would you like to ask?


PhotoMed's empirical data from real-world people reveal possible associations hidden in plain sight. For example, the return-toward-normal function makes the difference being alive or inanimate.

Pioneers can now examine existing data to find possible associations among multiple sources of chronic pain. The relative time of resolution, for example, suggests association or independence of separate sources of pain.


Below is a map of clinical disorders and underlying impaired functions found to respond in 3 visits or less.

Disorders that responded to PhotoMed's therapy during the first or second.


A point to ponder

When is "evidence" of benefit relevant?


PhotoMed's studies aimed to find the "dose" (parameters) that are most effective and efficient for prompting the end of a chronic pain state. Evidence accrues while benefits persist after therapy ends.


Launching "open" science for healing data

PhotoMed's team is excited to begin working with the National Foundation for Integrative Medicine. Our mutual aim includes providing wide access to empirical data by researchers. We envision an era of "open" science about myriad non-invasive methods that can prompt healing.

What questions will millions of curious people around the globe ask and possibly answer?



The importance of observation methods and tools

Horse in motion image opened  photography for measuring motion Consider the impact of the first image that showed all feet of a horse at gallop off the ground at the same time. That was in 1878

PhotoMed's inventions, methods, and tools enable pioneers to open new areas of study, just as did the microscope, X-ray, and MRI...



PhotoMed Technologies team seeks visionaries, pioneers, partners, funding, and relationships with organizations and companies that can quickly advance care from demonstration studies to clinics around the globe.

We are working with the National Foundation for Integrative Medicine to begin outfitting pioneers with PhotoMed's methods and tools.

Updated: April 2, 2018



PhotoMed Technologies is a dedicated to finding non-invasive solutions to chronic pain and functional impairments.

Founded and funded as our family mission to help people with no path forward. We appreciate your donations and support.

Allan Gardiner


New Frontiers

PhotoMed's methods and equipment open new areas for pain, biophysics, physiology, neuroscience and other areas of research.

How can PhotoMed's team help you advance your mission?



PhotoMed Technologies envisions a future when collaborating clinics, including those rural and remote, can offer their patients the most current non-invasive solutions developed by passionate practitioners and researchers around the globe.


Get in Touch

(510) 526 7373


65 Franciscan Way
Kensington, CA 94707 USA




Ribbon Logo

Copyright © 2017-2018 · PhotoMed Technologies™, Inc. · All rights reserved

PhotoMed's products are for investigational use only. Methods and equipment may be covered by issued or pending patents.